✦ LIBER ✦

Pegylated interferon alfa-2B induced lupus in a patient with chronic hepatitis B virus infection: case report

✍ Scribed by Sema Yılmaz; Kadriye Akar Cimen

Book ID: 106265544
Publisher: Springer
Year: 2009
Tongue: English
Weight: 106 KB
Volume: 28
Category: Article
ISSN: 0770-3198
DOI: 10.1007/s10067-009-1239-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PEGylated interferon alfa-2b and ribavir

PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus–related systemic vasculitis

✍ Patrice Cacoub; David Saadoun; Nicolas Limal; Damien Sene; Olivier Lidove; Jean- 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

A viral kinetic study using pegylated in

A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative

✍ Vassiliki-Anastasia Sypsa; Konstantinos Mimidis; Nicholas C. Tassopoulos; Dimitr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

We studied viral dynamic parameters in 44 chronic hepatitis B/hepatitis B e antigen (HBeAg)(؊) patients treated with pegylated interferon alfa-2b (PEG-IFN) 100 or 200 g weekly or lamivudine 100 mg daily or the combination of PEG-IFN 100 or 200 g with lamivudine. Patients receiving PEG-IFN monotherap

Therapeutic effects of pegylated interfe

Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection

✍ Li-Wei Chen; Rong-Nan Chien; Cho-Li Yen; Jia-Jang Chang; Ching-Jung Liu; Chih-La 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

α-2-HS-glycoprotein is a potential marke

α-2-HS-glycoprotein is a potential marker predicting hepatitis B e antigen seroconversion in patients with chronic hepatitis B during treatment with pegylated interferon alfa-2b

✍ Hui Ma; JiangHua Wang; Fang Guo; Lai Wei 📂 Article 📅 2011 🏛 Science in China Press (SCP) 🌐 English ⚖ 719 KB

Lamivudine/pegylated interferon alfa-2b

Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B

✍ Themistoklis Vassiliadis; Konstantinos Tziomalos; Kalliopi Patsiaoura; Thomas Za 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Incidence of Neutropenia and Infections

Incidence of Neutropenia and Infections During Combination Treatment of Chronic Hepatitis C with Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin

✍ M. G. Antonini; S. Babudieri; I. Maida; C. Baiguera; B. Zanini; L. Fenu; G. Dett 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 271 KB